Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9309756rdf:typepubmed:Citationlld:pubmed
pubmed-article:9309756lifeskim:mentionsumls-concept:C0344432lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0040479lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0002598lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0034414lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0332624lld:lifeskim
pubmed-article:9309756lifeskim:mentionsumls-concept:C0442802lld:lifeskim
pubmed-article:9309756pubmed:issue9 Pt 1lld:pubmed
pubmed-article:9309756pubmed:dateCreated1997-11-6lld:pubmed
pubmed-article:9309756pubmed:abstractTextWe report a case of amiodarone induced torsades de pointes (TdP) associated with increase QT dispersion in a patient with a history of quinidine induced TdP. An increase in QT dispersion of > 100% was noted on the 12 lead surface ECG postamiodarone therapy. In summary, amiodarone has a potential to induce TdP in patients with a previous history of quinidine induced TdP. QT dispersion could be a potential marker of TdP in these patients.lld:pubmed
pubmed-article:9309756pubmed:languageenglld:pubmed
pubmed-article:9309756pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9309756pubmed:citationSubsetIMlld:pubmed
pubmed-article:9309756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9309756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9309756pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9309756pubmed:statusMEDLINElld:pubmed
pubmed-article:9309756pubmed:monthSeplld:pubmed
pubmed-article:9309756pubmed:issn0147-8389lld:pubmed
pubmed-article:9309756pubmed:authorpubmed-author:RossJJlld:pubmed
pubmed-article:9309756pubmed:authorpubmed-author:KlucárJJlld:pubmed
pubmed-article:9309756pubmed:authorpubmed-author:ChowM SMSlld:pubmed
pubmed-article:9309756pubmed:issnTypePrintlld:pubmed
pubmed-article:9309756pubmed:volume20lld:pubmed
pubmed-article:9309756pubmed:ownerNLMlld:pubmed
pubmed-article:9309756pubmed:authorsCompleteYlld:pubmed
pubmed-article:9309756pubmed:pagination2275-8lld:pubmed
pubmed-article:9309756pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:meshHeadingpubmed-meshheading:9309756-...lld:pubmed
pubmed-article:9309756pubmed:year1997lld:pubmed
pubmed-article:9309756pubmed:articleTitleAmiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.lld:pubmed
pubmed-article:9309756pubmed:affiliationDivision of Cardiovascular Therapeutics, Hartford Hospital, Connecticut 06102-5037, USA.lld:pubmed
pubmed-article:9309756pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9309756pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9309756lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9309756lld:pubmed